CS594082A2 - Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production - Google Patents

Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production Download PDF

Info

Publication number
CS594082A2
CS594082A2 CS825940A CS594082A CS594082A2 CS 594082 A2 CS594082 A2 CS 594082A2 CS 825940 A CS825940 A CS 825940A CS 594082 A CS594082 A CS 594082A CS 594082 A2 CS594082 A2 CS 594082A2
Authority
CS
Czechoslovakia
Prior art keywords
group
compound
hydroxy
formula
mixture
Prior art date
Application number
CS825940A
Other languages
Czech (cs)
English (en)
Inventor
Howard J Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CS594082A2 publication Critical patent/CS594082A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
CS825940A 1981-08-11 1982-08-10 Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production CS594082A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8124444 1981-08-11

Publications (1)

Publication Number Publication Date
CS594082A2 true CS594082A2 (en) 1989-08-14

Family

ID=10523843

Family Applications (1)

Application Number Title Priority Date Filing Date
CS825940A CS594082A2 (en) 1981-08-11 1982-08-10 Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production

Country Status (25)

Country Link
EP (1) EP0072027B1 (fr)
JP (1) JPS5841879A (fr)
KR (1) KR880002276B1 (fr)
AT (2) ATE34393T1 (fr)
AU (1) AU569462B2 (fr)
CA (1) CA1305138C (fr)
CS (1) CS594082A2 (fr)
DD (1) DD202717A5 (fr)
DE (1) DE3278501D1 (fr)
DK (1) DK154561C (fr)
ES (3) ES8403128A1 (fr)
FI (1) FI76086C (fr)
GB (1) GB2104070B (fr)
GR (1) GR76891B (fr)
HU (1) HU189609B (fr)
IE (1) IE54148B1 (fr)
MC (1) MC1475A1 (fr)
NO (1) NO158539C (fr)
NZ (1) NZ201547A (fr)
PH (3) PH19940A (fr)
PL (3) PL247394A1 (fr)
PT (1) PT75406B (fr)
ZA (1) ZA825792B (fr)
ZM (1) ZM6082A1 (fr)
ZW (1) ZW16882A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
EP0095813A3 (fr) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Compositions pharmaceutiques topiques pénétrantes contenant la 9-(2-hydroxyéthoxyméthyl)-guanine
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
AU577303B2 (en) * 1983-08-18 1988-09-22 Novartis International Pharmaceutical Ltd 9-substituted-2-amino purines
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
EP0141927B1 (fr) * 1983-08-18 1991-10-30 Beecham Group Plc Dérivés de guanine antiviraux
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (fr) * 1983-09-30 1988-01-20 Merck & Co. Inc. Dérivés de purine, leur application dans des compositions anti-virales
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0190123A1 (fr) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Compose immunoregulateur et anti-viral
EP0203736B1 (fr) 1985-05-02 1989-11-23 The Wellcome Foundation Limited Composés antiviraux
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3627024A1 (de) 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE68922903T2 (de) * 1988-12-19 1995-11-23 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
DE4020481A1 (de) * 1990-06-27 1992-01-02 Hoechst Ag Verfahren zur herstellung von substituierten acyclischen nukleosiden und dabei auftretende zwischenprodukte
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
CA2152863A1 (fr) * 1994-07-26 1996-01-27 Yeun-Kwei Han Preparation d'acyclovir
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5559114A (en) * 1994-12-16 1996-09-24 Exley; Ray W. Treatment of autoimmune disease using 2-amino purine derivatives
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent

Also Published As

Publication number Publication date
HU189609B (en) 1986-07-28
ES514877A0 (es) 1983-10-01
ATE34393T1 (de) 1988-06-15
NO822725L (no) 1983-02-14
NZ201547A (en) 1986-01-24
ES8504802A1 (es) 1985-04-16
ZW16882A1 (en) 1984-03-14
DD202717A5 (de) 1983-09-28
PH20148A (en) 1986-10-08
DK154561C (da) 1989-04-24
PL247393A1 (en) 1984-10-22
MC1475A1 (fr) 1983-06-17
GB2104070A (en) 1983-03-02
PH19940A (en) 1986-08-14
JPS5841879A (ja) 1983-03-11
KR880002276B1 (ko) 1988-10-21
EP0072027B1 (fr) 1988-05-18
PL141281B1 (en) 1987-07-31
ZM6082A1 (en) 1984-04-23
AT380252B (de) 1986-05-12
DK359082A (da) 1983-02-12
ES521550A0 (es) 1985-04-16
AU8702082A (en) 1983-05-05
DK154561B (da) 1988-11-28
ES8502117A1 (es) 1984-12-16
PL247394A1 (en) 1984-10-22
JPH04989B2 (fr) 1992-01-09
EP0072027A1 (fr) 1983-02-16
FI76086C (fi) 1988-09-09
GR76891B (fr) 1984-09-04
NO158539B (no) 1988-06-20
ES8403128A1 (es) 1983-10-01
FI822783A0 (fi) 1982-08-10
ZA825792B (en) 1984-03-28
PT75406A (en) 1982-09-01
PH18814A (en) 1985-09-27
NO158539C (no) 1988-09-28
FI76086B (fi) 1988-05-31
DE3278501D1 (en) 1988-06-23
AU569462B2 (en) 1988-02-04
ES521551A0 (es) 1984-12-16
IE54148B1 (en) 1989-07-05
CA1305138C (fr) 1992-07-14
PL141198B1 (en) 1987-07-31
IE821921L (en) 1983-02-11
ATA306082A (de) 1985-09-15
KR840001169A (ko) 1984-03-28
FI822783L (fi) 1983-02-12
GB2104070B (en) 1985-08-14
PL237847A1 (en) 1984-09-10
PT75406B (en) 1985-11-15

Similar Documents

Publication Publication Date Title
CS594082A2 (en) Method of antiviral effective 2-amino-9-/(2-hydroxy-1-hydroxymethyl-ethoxy)methyl/purines production
EP0308065B1 (fr) Nucléosides thérapeutiques
US4957924A (en) Therapeutic valine esters of acyclovir and pharmaceutically acceptable salts thereof
US4474806A (en) Sulfonyl or carbonyl inositol derivatives useful as anti-inflammatory/analgesic agents
FI76087B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 9-(2-hydroxietoximetyl)guaninderivat.
KR100282584B1 (ko) 뉴클레오시드 치료제
JP4782365B2 (ja) ウイルス感染症と癌細胞を二重ターゲッティングする組成物及び方法
FI74468C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 2-aminopurinderivat.
US20100130440A1 (en) Antiviral nucleosides
JP5031162B2 (ja) ウイルス感染を二重ターゲティングおよびガン細胞をターゲティングするための組成物および方法
EP0173624A2 (fr) 4-(Guanin-9-yl)butanales et compositions antivirales les contenant
US4544634A (en) Method of producing acyclovir
US4695570A (en) Antiviral compound use
EP0366385A1 (fr) Dérivés de guanine ayant une activité anti-virale et leurs sels pharmaceutiquement acceptables
JPH0273086A (ja) 治療用化合物
NZ205802A (en) Phosphate ester derivatives of guanine as antiviral agents
DE60008580T2 (de) (1s, cis)-4-(2-amino-9h-purin-9-yl)-2-cyclopenten-1-methanol analogue als antiviral
EP1150981B1 (fr) Utilisation de (1r,4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol dans hbv
CA1340084C (fr) Esters de 9-(hydroxethoxymethyl)guanine possedant des proprietes antivirales
CS244679B2 (en) Production method of anti virus effective compound
HU194565B (en) Process for production of salts of 9-/1,3-dihydroxi-2-propoximethil/-guanin-chained-phosphor esther and antivirus compounds containing such compounds